$28.440
+3.254 (+11.44%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CUE por análisis de gráficos similares
Alphio's CUE stock price prediction model matches the current Cue Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.62 (-2.88%). The 1-week path is $27.38 (-3.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cue Biopharma Inc?
Cue Biopharma Inc is a good buy right now, primarily driven by its recent revenue growth of 175.44% year-to-date and a current price of $27.88, which is significantly lower than its 52-week high of $45.50. The company's recent appointment of a new CFO and advancements in its clinical pipeline, including the upcoming Phase 2 data for CUE-221, indicate strong potential for future growth. However, the main risk is the recent net loss of $153.07 million in Q2 2026, which raises concerns about financial stability.
CUE cerró en $28.44 el Tuesday, tras subir +11.44%
Cue Biopharma Inc (CUE) last closed at $28.44, gaining +11.44%. These facts feed the 1-day and 1-week CUE price prediction above.
Consenso de analistas
Cue Biopharma Inc (CUE): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Cue Biopharma Inc (CUE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CUE, ordenadas por similitud.
Análisis de estacionalidad de CUE
Historically the probability of a positive September return for CUE is 2.38%. January offers the highest probability of a positive month at 73.77%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.